Zobrazeno 11 - 20
of 150
pro vyhledávání: '"Michael R Migden"'
Publikováno v:
Oncotarget
Although basal cell carcinoma (BCC) is often managed successfully with surgery, patients with locally advanced BCC (laBCC) or metastatic BCC (mBCC) who are not candidates for surgery or radiotherapy have limited treatment options. Most BCCs result fr
Publikováno v:
Clinics in Dermatology.
Dermatology is a specialty reliant on presenting detailed and accurate visual observations. Digital photography is a highly prevalent and accessible technology that can be easily incorporated into a dermatology practice to facilitate documentation an
Autor:
Karl D Lewis, Ketty Peris, Aleksandar Sekulic, Alexander J Stratigos, Lara Dunn, Zeynep Eroglu, Anne Lynn S Chang, Michael R Migden, Suk-Young Yoo, Kosalai Mohan, Ebony Coates, Emmanuel Okoye, Jean-François Baurain, Oliver Bechter, Axel Hauscild, Marcus O Butler, Leonel Hernandez-Aya, Lisa Licitra, Rogerio I Neves, Emily S Ruiz, Frank Seebach, Israel Lowy, Priscila Goncalves, Matthew G Fury
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 7:s177
Autor:
Alexander J Stratigos, Aleksandar Sekulic, Ketty Peris, Oliver Bechter, Sorilla Prey, Martin Kaatz, Karl D Lewis, Nicole Basset-Seguin, Anne Lynn S Chang, Stéphane Dalle, Almudena Fernandez Orland, Lisa Licitra, Caroline Robert, Claas Ulrich, Axel Hauschild, Michael R Migden, Reinhard Dummer, Suk-Young Yoo, Ebony Coates, Emmanuel Okoye, Ioannis Bassukas, Carmen Loquai, Vincenzo De Giorgi, Zeynep Eroglu, Ralf Gutzmer, Jens Ulrich, Susana Puig, Frank Seebach, Israel Lowy, Matthew G Fury
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 7:s178
Autor:
Amy C. Moreno, Michael K. Wong, Randal S. Weber, Priyadharsini Nagarajan, Michael R. Migden, David I. Rosenthal, Bonnie S. Glisson, Renata Ferrarotto, Neil D. Gross, Avi Benov, Anshu Khanna, Jeffrey N. Myers, Ryan P. Goepfert, Guojun Li, Sameer Kini, Frederico Omar Netto Gleber, Samantha Tam, Adel K. El-Naggar, Moran Amit, Mohamed Aashiq, Chuan Liu
Publikováno v:
European Journal of Cancer. 144:169-177
Background The last revision of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual included a specific system for cutaneous squamous cell carcinoma (CSCC) of the head and neck. Here, we assessed the prognostic performance of six cand
Publikováno v:
Dermatologic Surgery. 47:1273-1275
Publikováno v:
Journal of Drugs in Dermatology. 20:156-165
Basal cell carcinoma (BCC) is the most common malignancy in fair-skinned populations. Most cases are successfully treated with surgery, but in advanced BCCmdash;including locally advanced BCC and metastatic BCCmdash;surgery is likely to result in sub
Autor:
Aleksandar Sekulic, Michael R. Migden, Nicole Basset-Seguin, Claus Garbe, Anja Gesierich, Christopher D. Lao, Chris Miller, Laurent Mortier, Dedee F. Murrell, Omid Hamid, Jorge F. Quevedo, Jeannie Hou, Edward McKenna, Natalie Dimier, Sarah Williams, Dirk Schadendorf, Axel Hauschild, for the ERIVANCE BCC Investigators
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-1 (2019)
Following publication of the original article [1], it was reported that the legend for Fig. 1 was incomplete. The complete figure legend is:
Externí odkaz:
https://doaj.org/article/c7f86cdcb25043d29d5876749e8c0149
Autor:
Randal S. Weber, Guojun Li, Samantha Tam, Bonnie S. Glisson, Jeffrey N. Myers, Chuan Liu, Sameer Kini, Mohamed Aashiq, Neil D. Gross, Moran Amit, Avi Benov, Michael K. Wong, Anshu Khanna, Adel K. El-Naggar, Priyadharsini Nagarajan, Ryan P. Goepfert, Frederico O. Gleber-Netto, Amy C. Moreno, Renata Ferrarotto, Michael R. Migden, David I. Rosenthal, Erez N. Baruch
Publikováno v:
Cancer. 127:1238-1245
Background The prognostic performance of the recently updated American Joint Committee on Cancer lymph node classification of cutaneous head and neck squamous cell carcinoma (HNSCC) has not been validated. The objective of this study was to assess th
Autor:
Wanxing Chai-Ho, Jenny H. Lee, Ignacio Melero, Andrew Haydon, Nikhil I. Khushalani, Jose Lutzky, Andrew F. Hill, Gregory A. Daniels, Muhammad Alamgeer, Ragini R. Kudchadkar, Dimitrios Colevas, Ann Silk, Piyush Sheladia, Daniel Brungs, Shui He, Praveen K. Bommareddy, Frances A. Collichio, Samantha Bowyer, Céleste Lebbé, Michael R. Migden, Danny Rischin, Jean-jaques Grob, Matthew G. Fury, Claudia Andreu-Vieyra
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundThe prognosis for advanced and metastatic cutaneous squamous cell carcinoma (CSCC) remains poor for many patients with the disease despite approval of the anti-PD1 antibodies cemiplimab and pembrolizumab.1 2 RP1 is an oncolytic virus (HSV-1